Single award · contract
Purchase of a Total of 614,000 Doses of Combination Monoclonal Antibody
Award ID: W58P0522F0001
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
$1.3B
Total award value
Award W58P0522F0001 is a contract from the Department of Defense to Eli Lilly and Company, $1.3B obligated, FY2022, for Purchase of a Total of 614,000 Doses of Combination Monoclonal Antibody. The work is performed in Indiana. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source
Agency ›
Department of Defense
Source
awarded→$1.3B
Recipient ›
Eli Lilly and Company
Source
performed in→
Description
Purchase of a Total of 614,000 Doses of Combination Monoclonal Antibody.
Award details
Award typeContract
PIIDW58P0522F0001
Action date2021
Period4 mo
Awarding agencyDepartment of Defense →
RecipientEli Lilly and Company →
Place of performanceIndiana →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$1,289,400,000
More awards to Eli Lilly and Company
awarded 2022$1.5B
awarded 2020$1.4B
awarded 2021$329.8M
awarded 2021$210M
More from Department of Defense
awarded 2016$51.3B
awarded 2017$35.7B
awarded 2017$35.1B
awarded 2001$34.2B
awarded 2011$32B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.